Synthesis of the heparin-based anticoagulant drug fondaparinux.

Cheng-Hsiu Chang,Larry S. Lico,Teng-Yi Huang,Shu‐Yi Lin,Chi-Liang Chang,Susan D. Arco,S. Hung

DOI: https://doi.org/10.1002/anie.201404154

2014-09-08

Angewandte Chemie

Abstract:Fondaparinux, a synthetic pentasaccharide based on the heparin antithrombin-binding domain, is an approved clinical anticoagulant. Although it is a better and safer alternative to pharmaceutical heparins in many cases, its high cost, which results from the difficult and tedious synthesis, is a deterrent for its widespread use. The chemical synthesis of fondaparinux was achieved in an efficient and concise manner from commercially available D-glucosamine, diacetone α-D-glucose, and penta-O-acetyl-D-glucose. The method involves suitably functionalized building blocks that are readily accessible and employs shared intermediates and a series of one-pot reactions that considerably reduce the synthetic effort and improve the yield.